Allianz Asset Management GmbH - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$275,798
-94.5%
7,400
-92.3%
0.00%
-100.0%
Q2 2022$4,975,000
-6.0%
96,118
+31.9%
0.01%
+25.0%
Q1 2022$5,295,000
-46.0%
72,852
-12.0%
0.00%
-42.9%
Q4 2021$9,803,000
-5.7%
82,740
+6.8%
0.01%
-12.5%
Q3 2021$10,396,000
+28.1%
77,495
+54.6%
0.01%
+14.3%
Q2 2021$8,118,000
+165.0%
50,141
+31.4%
0.01%
+133.3%
Q1 2021$3,063,000
+35.1%
38,169
-8.4%
0.00%
+50.0%
Q4 2020$2,268,000
+170.3%
41,689
-39.2%
0.00%
+100.0%
Q1 2020$839,000
-44.6%
68,595
-33.5%
0.00%0.0%
Q4 2019$1,514,000
+24.1%
103,183
+12.9%
0.00%0.0%
Q3 2019$1,220,000
-59.4%
91,389
-50.3%
0.00%
-66.7%
Q2 2019$3,007,000
+3.0%
183,703
+7.5%
0.00%0.0%
Q1 2019$2,919,000
+66.5%
170,925
+33.1%
0.00%
+50.0%
Q4 2018$1,753,000
-49.7%
128,392
+5.5%
0.00%
-33.3%
Q3 2018$3,482,000
+59.3%
121,654
+52.3%
0.00%
+50.0%
Q2 2018$2,186,00079,8890.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders